Abstract
Background: Bone Tuberculosis of the skull base as well as maxillofacial and oral cavity involvement can rarely and only occur in about 3% of the cases with systemic diseases or in case of pulmonary involvement.
Case Presentation: A 37-year-old patient with fever and swelling in his face and neck referred to our center. After MRI and CT scan, it was revealed that multiple erosions and destructions are seen in the Hard Palate bones, as well as the pre-maxillary process, alveolar ridge, and the floor of maxillary sinus on both sides. In the Ziel Nelson staining, there were 5 Acid-fast bacilli in each field. The patient received standard anti-tuberculosis and clarithromycin therapy. In the follow-up three months later, the patient’s condition improved and MRI showed significant remission. Conclusion: The present case confirms that tuberculosis may occur in patients with skull bone involvement and osteolytic lesions whose early diagnosis and treatment can result in gaining good outcomes.Keywords: Tuberculosis, skull bone, maxillary, osteolytic lesions, destruction, Ziel Nelson staining.
Graphical Abstract
Infectious Disorders - Drug Targets
Title:Multifocal Osteolytic Lesions in Skull Bone with Mycobacterium Tuberculosis: A Case Report
Volume: 21 Issue: 5
Author(s): Milad Mellat-Ardakani, Fereshteh Ghiasvand, Malihe Hassan Nezhad, Faeze Salahshour and SeyedAhmad SeyedAlinaghi*
Affiliation:
- Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran,Iran
Keywords: Tuberculosis, skull bone, maxillary, osteolytic lesions, destruction, Ziel Nelson staining.
Abstract: Background: Bone Tuberculosis of the skull base as well as maxillofacial and oral cavity involvement can rarely and only occur in about 3% of the cases with systemic diseases or in case of pulmonary involvement.
Case Presentation: A 37-year-old patient with fever and swelling in his face and neck referred to our center. After MRI and CT scan, it was revealed that multiple erosions and destructions are seen in the Hard Palate bones, as well as the pre-maxillary process, alveolar ridge, and the floor of maxillary sinus on both sides. In the Ziel Nelson staining, there were 5 Acid-fast bacilli in each field. The patient received standard anti-tuberculosis and clarithromycin therapy. In the follow-up three months later, the patient’s condition improved and MRI showed significant remission. Conclusion: The present case confirms that tuberculosis may occur in patients with skull bone involvement and osteolytic lesions whose early diagnosis and treatment can result in gaining good outcomes.Export Options
About this article
Cite this article as:
Mellat-Ardakani Milad , Ghiasvand Fereshteh , Nezhad Hassan Malihe , Salahshour Faeze and SeyedAlinaghi SeyedAhmad *, Multifocal Osteolytic Lesions in Skull Bone with Mycobacterium Tuberculosis: A Case Report, Infectious Disorders - Drug Targets 2021; 21 (5) : e270421187878 . https://dx.doi.org/10.2174/1871526520999201111200140
DOI https://dx.doi.org/10.2174/1871526520999201111200140 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Insight and Binding Pattern Analysis of Shikonin as a Potential VEGFR-2 Inhibitor
Current Enzyme Inhibition The Role of Machine Learning in Centralized Authorization Process of Nanomedicines in European Union
Current Topics in Medicinal Chemistry Disseminated TB in an Immunocompetent Patient: A Case Report
Infectious Disorders - Drug Targets Direct Evidence on the Immune-Mediated Spontaneous Regression of Human Cancer: An Incentive for Pharmaceutical Companies to Develop a Novel Anti-Cancer Vaccine
Current Pharmaceutical Design Mechanisms at the Interface of Innate and Adaptive Immunity in the Pathogenesis of RSV Disease: Lessons from the Mouse Model
Current Respiratory Medicine Reviews Pregnane X Receptor (PXR) at the Crossroads of Human Metabolism and Disease
Current Drug Metabolism Anti-Tuberculosis Drug Induced Hepatotoxicity and Genetic Polymorphisms in Drug-metabolizing Genes
Current Pharmacogenomics Computer Aided Drug Design: Success and Limitations
Current Pharmaceutical Design The Battle for Iron between Humans and Microbes
Current Medicinal Chemistry Angiogenic and Antiangiogenic Factors in Proliferative Diabetic Retinopathy
Current Diabetes Reviews Enhancement of Immunoprotective Effect of CpG-ODN by Formulation with Polyphosphazenes Against E. coli Septicemia in Neonatal Chickens
Current Drug Delivery Fatty Acid Intakes and Coronary Heart Disease Mortality in Japan: NIPPON DATA90, 1990-2005
Current Nutrition & Food Science Clostridium difficile Infection in Children with Inflammatory Bowel Disease: Current Evidence
Current Pharmaceutical Design The Synthetic and Biological Attributes of Pyrazole Derivatives: A Review
Mini-Reviews in Medicinal Chemistry A Structural-Energetic Basis for B-Cell Epitope Prediction
Protein & Peptide Letters N-heterocycles: Recent Advances in Biological Applications
Mini-Reviews in Organic Chemistry Nebulizable Cycloserine Loaded PLGA Nanoparticles: Formulation Design, in vitro Evaluation and Stability Studies
Current Nanomedicine Patent Selections
Recent Patents on Anti-Infective Drug Discovery Biomarker Discovery in Clinical Proteomics: Strategies for Exposing Low Abundant Proteins
Current Proteomics Meet Our Regional Editor
Applied Clinical Research, Clinical Trials and Regulatory Affairs